Enlivex Ltd. (ENLV): Total Assets
$2.33B
As of 2025-12-31
+225.2%
3-year compound annual growth
n/m
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.33B | n/m | 2026-03-25, Balance as of period end |
| 2024-12-31 | $27.69M | -24.8% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $36.83M | -45.6% | 2025-04-30, Balance as of period end |
| 2022-12-31 | $67.64M | -28.9% | 2024-04-30, Balance as of period end |
| 2021-12-31 | $95.15M | +135.8% | 2023-04-10, Balance as of period end |
| 2020-12-31 | $40.36M | +129.8% | 2022-04-29, Balance as of period end |
| 2019-12-31 | $17.56M | +59.1% | 2021-04-30, Balance as of period end |
| 2018-12-31 | $11.03M | +204.6% | 2020-04-30, Balance as of period end |
| 2017-12-31 | $3.62M | -65.9% | 2020-01-23, Balance as of period end |
| 2016-12-31 | $10.63M | -48.2% | 2018-04-23, Balance as of period end |
| 2015-12-31 | $20.52M | -37.7% | 2017-02-24, Balance as of period end |
| 2014-12-31 | $32.95M | n/m | 2016-03-29, Balance as of period end |
| 2013-12-31 | $306.0K | n/a | 2015-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Enlivex Ltd. (ENLV) | 2025-12-31 | $2.33B | n/m |
| Insmed Inc (INSM) | 2025-12-31 | $2.26B | +11.8% |
| Alkermes plc. (ALKS) | 2025-12-31 | $2.49B | +21.0% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.93B | -12.2% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $2.90B | +70.0% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $1.75B | +37.6% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.66B | -0.4% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.64B | +25.7% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $1.63B | +3.3% |
Compare ENLV, INSM, ALKS, OPK side by side · Screen every company in Pharmaceutical Preparations ↗